453 related articles for article (PubMed ID: 20527935)
1. Small molecule modifiers of microRNA miR-122 function for the treatment of hepatitis C virus infection and hepatocellular carcinoma.
Young DD; Connelly CM; Grohmann C; Deiters A
J Am Chem Soc; 2010 Jun; 132(23):7976-81. PubMed ID: 20527935
[TBL] [Abstract][Full Text] [Related]
2. The liver-specific microRNA miR-122: biology and therapeutic potential.
Filipowicz W; Grosshans H
Prog Drug Res; 2011; 67():221-38. PubMed ID: 21141732
[TBL] [Abstract][Full Text] [Related]
3. Role of the miR-106b-25 microRNA cluster in hepatocellular carcinoma.
Li Y; Tan W; Neo TW; Aung MO; Wasser S; Lim SG; Tan TM
Cancer Sci; 2009 Jul; 100(7):1234-42. PubMed ID: 19486339
[TBL] [Abstract][Full Text] [Related]
4. MicroRNA-223 is commonly repressed in hepatocellular carcinoma and potentiates expression of Stathmin1.
Wong QW; Lung RW; Law PT; Lai PB; Chan KY; To KF; Wong N
Gastroenterology; 2008 Jul; 135(1):257-69. PubMed ID: 18555017
[TBL] [Abstract][Full Text] [Related]
5. [Construction and identification of the human liver-specific miR-122 expression vector].
Huang Z; Liu C
Sheng Wu Gong Cheng Xue Bao; 2009 Apr; 25(4):587-90. PubMed ID: 19637636
[TBL] [Abstract][Full Text] [Related]
6. Differential diagnosis of hepatocellular carcinoma from metastatic tumors in the liver using microRNA expression.
Barshack I; Meiri E; Rosenwald S; Lebanony D; Bronfeld M; Aviel-Ronen S; Rosenblatt K; Polak-Charcon S; Leizerman I; Ezagouri M; Zepeniuk M; Shabes N; Cohen L; Tabak S; Cohen D; Bentwich Z; Rosenfeld N
Int J Biochem Cell Biol; 2010 Aug; 42(8):1355-62. PubMed ID: 20619223
[TBL] [Abstract][Full Text] [Related]
7. Deregulation of miR-92a expression is implicated in hepatocellular carcinoma development.
Shigoka M; Tsuchida A; Matsudo T; Nagakawa Y; Saito H; Suzuki Y; Aoki T; Murakami Y; Toyoda H; Kumada T; Bartenschlager R; Kato N; Ikeda M; Takashina T; Tanaka M; Suzuki R; Oikawa K; Takanashi M; Kuroda M
Pathol Int; 2010 May; 60(5):351-7. PubMed ID: 20518884
[TBL] [Abstract][Full Text] [Related]
8. Regulation and biological function of the liver-specific miR-122.
Lewis AP; Jopling CL
Biochem Soc Trans; 2010 Dec; 38(6):1553-7. PubMed ID: 21118125
[TBL] [Abstract][Full Text] [Related]
9. MicroRNA-23b mediates urokinase and c-met downmodulation and a decreased migration of human hepatocellular carcinoma cells.
Salvi A; Sabelli C; Moncini S; Venturin M; Arici B; Riva P; Portolani N; Giulini SM; De Petro G; Barlati S
FEBS J; 2009 Jun; 276(11):2966-82. PubMed ID: 19490101
[TBL] [Abstract][Full Text] [Related]
10. MiR-122/cyclin G1 interaction modulates p53 activity and affects doxorubicin sensitivity of human hepatocarcinoma cells.
Fornari F; Gramantieri L; Giovannini C; Veronese A; Ferracin M; Sabbioni S; Calin GA; Grazi GL; Croce CM; Tavolari S; Chieco P; Negrini M; Bolondi L
Cancer Res; 2009 Jul; 69(14):5761-7. PubMed ID: 19584283
[TBL] [Abstract][Full Text] [Related]
11. [The relationship between microRNA-18 and BTG2 in the carcinogenesis of hepatocellular carcinoma].
Li Q; Wang G; Zhang ZM
Zhonghua Gan Zang Bing Za Zhi; 2009 Jan; 17(1):42-5. PubMed ID: 19203451
[TBL] [Abstract][Full Text] [Related]
12. Proteomic identification of microRNA-122a target proteins in hepatocellular carcinoma.
Diao S; Zhang JF; Wang H; He ML; Lin MC; Chen Y; Kung HF
Proteomics; 2010 Oct; 10(20):3723-31. PubMed ID: 20859956
[TBL] [Abstract][Full Text] [Related]
13. MicroRNA-500 as a potential diagnostic marker for hepatocellular carcinoma.
Yamamoto Y; Kosaka N; Tanaka M; Koizumi F; Kanai Y; Mizutani T; Murakami Y; Kuroda M; Miyajima A; Kato T; Ochiya T
Biomarkers; 2009 Nov; 14(7):529-38. PubMed ID: 19863192
[TBL] [Abstract][Full Text] [Related]
14. A functional polymorphism in the miR-146a gene is associated with the risk for hepatocellular carcinoma.
Xu T; Zhu Y; Wei QK; Yuan Y; Zhou F; Ge YY; Yang JR; Su H; Zhuang SM
Carcinogenesis; 2008 Nov; 29(11):2126-31. PubMed ID: 18711148
[TBL] [Abstract][Full Text] [Related]
15. Alterations in microRNA expression profile in HCV-infected hepatoma cells: involvement of miR-491 in regulation of HCV replication via the PI3 kinase/Akt pathway.
Ishida H; Tatsumi T; Hosui A; Nawa T; Kodama T; Shimizu S; Hikita H; Hiramatsu N; Kanto T; Hayashi N; Takehara T
Biochem Biophys Res Commun; 2011 Aug; 412(1):92-7. PubMed ID: 21802413
[TBL] [Abstract][Full Text] [Related]
16. MiR-199a-3p regulates mTOR and c-Met to influence the doxorubicin sensitivity of human hepatocarcinoma cells.
Fornari F; Milazzo M; Chieco P; Negrini M; Calin GA; Grazi GL; Pollutri D; Croce CM; Bolondi L; Gramantieri L
Cancer Res; 2010 Jun; 70(12):5184-93. PubMed ID: 20501828
[TBL] [Abstract][Full Text] [Related]
17. MicroRNA expression signature and antisense-mediated depletion reveal an essential role of MicroRNA in vascular neointimal lesion formation.
Ji R; Cheng Y; Yue J; Yang J; Liu X; Chen H; Dean DB; Zhang C
Circ Res; 2007 Jun; 100(11):1579-88. PubMed ID: 17478730
[TBL] [Abstract][Full Text] [Related]
18. Systematic identification of microRNA and messenger RNA profiles in hepatitis C virus-infected human hepatoma cells.
Liu X; Wang T; Wakita T; Yang W
Virology; 2010 Mar; 398(1):57-67. PubMed ID: 20006370
[TBL] [Abstract][Full Text] [Related]
19. miR-122 targets an anti-apoptotic gene, Bcl-w, in human hepatocellular carcinoma cell lines.
Lin CJ; Gong HY; Tseng HC; Wang WL; Wu JL
Biochem Biophys Res Commun; 2008 Oct; 375(3):315-20. PubMed ID: 18692484
[TBL] [Abstract][Full Text] [Related]
20. Discovery of small molecule modifiers of microRNAs for the treatment of HCV infection.
Tripp VT; Young DD
Methods Mol Biol; 2014; 1103():153-63. PubMed ID: 24318893
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
